Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients

NCT03295071 is registered in ClinicalTrials.gov with GenSight Biologics as lead sponsor.

NCT NCT03295071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03295071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Lead sponsor
GenSight Biologics
Phase
Observational
Overall status
Completed
Start date
January 3, 2018
Completion date
July 1, 2020
Enrollment
44 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

leber hereditary optic neuropathy